Andrew R Allen is PRESIDENT AND CEO of Gritstone bio, Inc.. Currently has a direct ownership of 985,360 shares of GRTS, which is worth approximately $29,560. The most recent transaction as insider was on Jun 24, 2024, when has been sold 325,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 985K
0% 3M change
15.01% 12M change
Total Value Held $29,560

Andrew R Allen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
SELL
Bona fide gift
-
325,000 Reduced 24.8%
985,360 Common Stock
May 16 2024
SELL
Open market or private sale
$18,197 $0.75 p/Share
24,263 Reduced 2.4%
985,360 Common Stock
May 15 2024
BUY
Grant, award, or other acquisition
-
47,873 Added 4.53%
1,009,623 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
105,000 Added 10.45%
899,345 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
738,550 Added 46.3%
856,750 Common Stock
Jan 31 2022
BUY
Grant, award, or other acquisition
-
70,000 Added 37.19%
118,200 Common Stock
Jan 07 2021
BUY
Grant, award, or other acquisition
-
48,200 Added 50.0%
48,200 Common Stock

Also insider at

ADAP
Adaptimmune Therapeutics PLC Healthcare
EPZM
Epizyme, Inc. Healthcare
TCRR
TCR2 THERAPEUTICS INC. Healthcare
SRRA
Sierra Oncology, Inc. Healthcare
ARA

Andrew R Allen

PRESIDENT AND CEO
Cambridge, MA

Track Institutional and Insider Activities on GRTS

Follow Gritstone bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRTS shares.

Notify only if

Insider Trading

Get notified when an Gritstone Bio, Inc. insider buys or sells GRTS shares.

Notify only if

News

Receive news related to Gritstone bio, Inc.

Track Activities on GRTS